Home
>
National Drug Code (NDC)
>
Trianex
Trianex - 0245-0136-17 - (triamcinolone acetonide)
Drug Information of Trianex
| Product NDC: | 0245-0136 |
| Proprietary Name: | Trianex |
| Non Proprietary Name: | triamcinolone acetonide |
| Active Ingredient(s): | .5 mg/g & nbsp; triamcinolone acetonide |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Trianex
| Product NDC: | 0245-0136 |
| Labeler Name: | Upsher-Smith Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA089595 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110527 |
Package Information of Trianex
| Package NDC: | 0245-0136-17 |
| Package Description: | 1 TUBE in 1 CARTON (0245-0136-17) > 17 g in 1 TUBE |
NDC Information of Trianex
| NDC Code | 0245-0136-17 |
| Proprietary Name | Trianex |
| Package Description | 1 TUBE in 1 CARTON (0245-0136-17) > 17 g in 1 TUBE |
| Product NDC | 0245-0136 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | triamcinolone acetonide |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20110527 |
| Marketing Category Name | ANDA |
| Labeler Name | Upsher-Smith Laboratories, Inc. |
| Substance Name | TRIAMCINOLONE ACETONIDE |
| Strength Number | .5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
